Stay updated on MAPP2 MDMA Therapy Clinical Trial
Sign up to get notified when there's something new on the MAPP2 MDMA Therapy Clinical Trial page.

Latest updates to the MAPP2 MDMA Therapy Clinical Trial page
- Check7 days agoChange DetectedPage revision updated from v3.6.3 to v3.6.4, signaling a small internal update to the page’s documentation and versioning.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page now shows a new revision label v3.6.3, replacing the previous v3.6.2.SummaryDifference0.0%

- Check35 days agoChange DetectedThe page revision was updated from v3.6.0 to v3.6.2, signaling a small software update to the ClinicalTrials.gov page. No study data, content, or details appear to be changed as part of this update.SummaryDifference0.0%

- Check49 days agoChange DetectedThe page adds new participant-focused sections (How to Read a Study Record, Common Questions, How to Join a Study) and marks recruitment as No longer looking for participants. The Intervention/Treatment label is updated and the revision tag advances to v3.6.0, replacing v3.5.5.SummaryDifference0.4%

- Check56 days agoChange DetectedThe page shows Revision: v3.5.5, replacing v3.5.4, indicating a small update to the study record's metadata rather than substantive content changes.SummaryDifference0.0%

- Check78 days agoChange DetectedThe study record version was updated from v3.5.3 to v3.5.4, representing a minor maintenance update to the ClinicalTrials.gov page. This change does not alter the study design, endpoints, eligibility criteria, or reported information.SummaryDifference0.0%

Stay in the know with updates to MAPP2 MDMA Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MAPP2 MDMA Therapy Clinical Trial page.